SCHEDULE: Vanguard Group Discloses 9.65% Stake in Avanos Medical Inc.

The Vanguard Group has filed an amended Schedule 13G, reporting a 9.65% beneficial ownership stake in Avanos Medical Inc. as of June 30, 2025.

Summary

• The Vanguard Group, based in Malvern, PA, is the reporting person for this Schedule 13G Amendment No. 11.
• Vanguard beneficially owns 4,464,896 shares of Avanos Medical Inc. Common Stock.
• This aggregate amount represents 9.65% of the class of securities.
• Vanguard holds sole voting power over 0 shares and shared voting power over 118,440 shares.
• Vanguard holds sole dispositive power over 4,281,879 shares and shared dispositive power over 183,017 shares.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Avanos Medical Inc.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that would inherently convey positive or negative sentiment about the company's performance or prospects.

Positives

• The continued significant ownership by a major institutional investor like The Vanguard Group (9.65%) indicates ongoing institutional confidence in Avanos Medical Inc.

Risks

• The filing explicitly states that the shares were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating risks associated with activist investor intervention from this specific holder.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Avanos Medical Inc.'s future performance or outlook.

Industry Context

The disclosure of a significant stake by a major asset manager like Vanguard is a routine event in the financial markets, reflecting their portfolio management activities across various industries, including the medical device sector where Avanos Medical Inc. operates.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, confirming continued institutional interest in the company.

Key Dates

Keywords

Avanos Medical Inc., Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Medical Devices